NASDAQ:CALA

Calithera Biosciences Stock Forecast

etoro logo Buy CALA
*Your capital is at risk
$0.0010
+0 (+0%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CALA
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Red day on Monday for Calithera Biosciences
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Oct 24, 2025 Gain 900.00%

No changes to the price of Calithera Biosciences stock on the last trading day (Monday, 17th Nov 2025). During the last trading day the stock fluctuated 0% from a day low at $0.0010 to a day high of $0.0010. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $0.0010 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 153.25% during the next 3 months and, with a 90% probability hold a price between $0.0015 and $0.0026 at the end of this 3-month period.

CALA Signals & Forecast

The Calithera Biosciences stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0010 and $0.0004. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, November 14, 2025, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Calithera Biosciences stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 0%.

Our recommended stop-loss: $0.0010 (-4.00%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CALA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Calithera Biosciences to open at $0.0010, and during the day (based on 14 day Average True Range), to move between $0.0010 and $0.0010, which gives a possible trading interval of +/-$0.00003563531709 (+/-3.63%) up or down from last closing price. If Calithera Biosciences takes out the full calculated possible swing range there will be an estimated 3.63% move between the lowest and the highest trading price during the day.

Is Calithera Biosciences stock A Buy?

Calithera Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.957 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.0010 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CALA Performance

Trading levels for CALA

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0010 -
R2 0.0010 -
R1 0.0010 -
Price 0.0010
S1 0.0010 -
S2 0.0010 -
S3 0.0010 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0010
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Calithera Biosciences Stock and on which exchange is it traded?
The symbol for Calithera Biosciences is CALA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Calithera Biosciences Stock?
Calithera Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Calithera Biosciences Stock?
Calithera Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Calithera Biosciences Stock.

What's the current price of Calithera Biosciences Stock?
As of the end of day on the Nov 17, 2025, the price of an Calithera Biosciences (CALA) share was $0.0010.

What is the 52-week high and low for Calithera Biosciences Stock?
The 52-week high for Calithera Biosciences Stock is $0.0100 and the 52-week low is $0.0001000000.

What is the market capitalization of Calithera Biosciences Stock?
As of the Nov 17, 2025, the market capitalization of Calithera Biosciences is 4.873K.
Click to get the best stock tips daily for free!
ABOUT CALITHERA BIOSCIENCES
Calithera Biosciences
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE